Skip to content
10-Q

Quarterly Report

RHYTHM PHARMACEUTICALS, INC. RYTM

0001558370-25-010302

← back to feed
Filed
Aug 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 66.42M sh
Shares Diluted Q2 2025 · Jun 30, 2025 63.68M sh
Shares Diluted Q2 2025 · Jun 30, 2025 63.37M sh
Shares Diluted Q2 2025 · Jun 30, 2024 61.01M sh
Shares Diluted Q2 2025 · Jun 30, 2024 60.58M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$63.66M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$69.82M
Long Term Debt Q2 2025 · Jun 30, 2025 $106.01M
Long Term Debt Q2 2025 · Dec 31, 2024 $108.27M
Short Term Debt Q2 2025 · Jun 30, 2025 $3.78M
Short Term Debt Q2 2025 · Dec 31, 2024 $1.54M
Short Term Investments Q2 2025 · Jun 30, 2025 $155.44M
Short Term Investments Q2 2025 · Dec 31, 2024 $231.43M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $135.59M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $89.14M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$11.91M
Stockholders Equity Q2 2025 · Mar 31, 2025 $18.95M
Stockholders Equity Q2 2025 · Dec 31, 2024 $21.73M
Stockholders Equity Q2 2025 · Jun 30, 2024 $39.34M
Stockholders Equity Q2 2025 · Mar 31, 2024 $61.58M
Stockholders Equity Q2 2025 · Dec 31, 2023 $169.76M
Current Liabilities Q2 2025 · Jun 30, 2025 $129.46M
Current Liabilities Q2 2025 · Dec 31, 2024 $115.52M
Total Liabilities Q2 2025 · Jun 30, 2025 $239.15M
Total Liabilities Q2 2025 · Dec 31, 2024 $227.72M
Current Assets Q2 2025 · Jun 30, 2025 $360.68M
Current Assets Q2 2025 · Dec 31, 2024 $374.2M
Total Assets Q2 2025 · Jun 30, 2025 $372.73M
Total Assets Q2 2025 · Dec 31, 2024 $392.27M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.75
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.56
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.55
Eps Diluted Q2 2025 · Jun 30, 2024 −$2.89
Eps Basic Q2 2025 · Jun 30, 2025 −$0.75
Eps Basic Q2 2025 · Jun 30, 2025 −$1.56
Eps Basic Q2 2025 · Jun 30, 2024 −$0.55
Eps Basic Q2 2025 · Jun 30, 2024 −$2.89
Sga Expense Q2 2025 · Jun 30, 2025 $45.95M
Sga Expense Q2 2025 · Jun 30, 2025 $85.03M
Sga Expense Q2 2025 · Jun 30, 2024 $36.42M
Sga Expense Q2 2025 · Jun 30, 2024 $70.8M
Rd Expense Q2 2025 · Jun 30, 2025 $42.31M
Rd Expense Q2 2025 · Jun 30, 2025 $79.28M
Rd Expense Q2 2025 · Jun 30, 2024 $30.19M
Rd Expense Q2 2025 · Jun 30, 2024 $158.86M
Net Income Q2 2025 · Jun 30, 2025 −$46.63M
Net Income Q2 2025 · Jun 30, 2025 −$96.13M
Net Income Q2 2025 · Mar 31, 2025 −$49.5M
Net Income Q2 2025 · Jun 30, 2024 −$32.26M
Net Income Q2 2025 · Jun 30, 2024 −$173.63M
Net Income Q2 2025 · Mar 31, 2024 −$141.37M
Operating Income Q2 2025 · Jun 30, 2025 −$45.3M
Operating Income Q2 2025 · Jun 30, 2025 −$92.3M
Operating Income Q2 2025 · Jun 30, 2024 −$40.48M
Operating Income Q2 2025 · Jun 30, 2024 −$180.36M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $5.54M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $9.19M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $2.95M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $5.75M
Revenue Q2 2025 · Jun 30, 2025 $48.5M
Revenue Q2 2025 · Jun 30, 2025 $81.21M
Revenue Q2 2025 · Jun 30, 2024 $29.08M
Revenue Q2 2025 · Jun 30, 2024 $55.05M